Bright Minds Biosciences DRUG
NASDAQ DRUG
$49.82 +0.08 (+0.16%)
At close: Sep 30, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Operating Expenses (2019 - 2026)

Updated

Bright Minds Biosciences (DRUG) posted Operating Expenses of $6.97 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 238.2% from $2.06 million a year earlier but down 30.7% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Operating Expenses (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Bright Minds Biosciences was $25.01 million, down 100.0% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $8.49 million, down 100.0% from FY2024.

  • In prior fiscal years, Bright Minds Biosciences' Operating Expenses was $867.55 billion in FY2024, -$5.47 trillion in FY2023, -$11.72 trillion in FY2022 and -$6.84 trillion in FY2021.
  • Quarterly Operating Expenses has run from a low of -$354,972 in fiscal Q3 2024 to a high of $9.71 trillion in fiscal Q4 2022 over five years.
  • On a year-over-year basis, Operating Expenses has increased in each of the last three quarters, with growth averaging 148.4% over the last six quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was fiscal Q1 2026, with growth of 436.3%; the weakest was fiscal Q4 2025, with a decline of 100.0%.
  • According to Business Quant data, Operating Expenses for the three prior fiscal quarters was $10.06 million (Q2 2026), $4.31 million (Q1 2026) and $3.67 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Bright Minds Biosciences 380.42 Mn 380.42 Mn - 6.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.97 Mn
Mar 31, 2026 10.06 Mn
Dec 31, 2025 4.31 Mn
Sep 30, 2025 3.67 Mn
Jun 30, 2025 2.06 Mn
Mar 31, 2025 1.98 Mn
Dec 31, 2024 803,852.77
Sep 30, 2024 865.01 Bn
Jun 30, 2024 -354,971.66
Mar 31, 2024 119,587.83
Dec 31, 2023 951,047.22
Sep 30, 2023 3,729.61 Bn
Jun 30, 2023 873,040.99
Mar 31, 2023 1.14 Mn
Dec 31, 2022 1.12 Mn
Sep 30, 2022 9,706.38 Bn
Jun 30, 2022 1.68 Mn
Mar 31, 2022 3.01 Mn
Dec 31, 2021 3.22 Mn
Sep 30, 2021 5,172.49 Bn
API Access

Bright Minds Biosciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=DRUG&period=max&api_key=YOUR_API_KEY